scispace - formally typeset
L

Li-Ming Gan

Researcher at AstraZeneca

Publications -  133
Citations -  4848

Li-Ming Gan is an academic researcher from AstraZeneca. The author has contributed to research in topics: Heart failure & Coronary artery disease. The author has an hindex of 32, co-authored 121 publications receiving 3353 citations. Previous affiliations of Li-Ming Gan include Sahlgrenska University Hospital & University of Gothenburg.

Papers
More filters
Journal ArticleDOI

PanglaoDB: a web server for exploration of mouse and human single-cell RNA sequencing data.

TL;DR: An online database, PanglaoDB, accessible through a user-friendly interface that can be used to explore published mouse and human single cell RNA sequencing studies, and establishes a community-curated cell-type marker compendium, containing more than 6000 gene-cell-type associations, as a resource for automatic annotation of cell types.
Journal ArticleDOI

Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction: PROMIS-HFpEF.

TL;DR: PROMIS-HFpEF is the first prospective multi-centre, multinational study to demonstrate a high prevalence of CMD in HFpEF in the absence of unrevascularized macrovascular CAD, and to show its association with systemic endothelial dysfunction (RHI, UACR as well as markers of HF severity (NTproBNP and RV dysfunction).
Journal ArticleDOI

Ticagrelor Enhances Adenosine-Induced Coronary Vasodilatory Responses in Humans

TL;DR: Ticagrelor enhanced adenosine-induced CBFV and the sensation of dyspnea in these healthy male subjects via an adenosinesine-mediated mechanism.
Journal ArticleDOI

Long non-coding RNA ANRIL regulates inflammatory responses as a novel component of NF-κB pathway.

TL;DR: The newly identified TNF-α-NF-κB-ANRIL/YY1-IL6/8 pathway enhances understanding of the etiology of CAD and provides potential therapeutic target for treatment of CAD.